2026. Targeted Nano-Encapsulated Ceftriaxone: Ligand–Receptor Interactions and Strategies to Overcome Efflux Pump-Mediated Resistance. Pakistan Journal of Medical & Cardiological Review. 5, 1 (Mar. 2026), 5711–5750. DOI:https://doi.org/10.5281/zenodo.21921749.